Annual Shareholders Equity
$22.69 M
-$19.77 M-46.55%
December 31, 2023
Summary
- As of February 7, 2025, XGN annual stockholders equity is $22.69 million, with the most recent change of -$19.77 million (-46.55%) on December 31, 2023.
- During the last 3 years, XGN annual shareholders equity has fallen by -$19.14 million (-45.76%).
- XGN annual shareholders equity is now -73.28% below its all-time high of $84.94 million, reached on December 31, 2021.
Performance
XGN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$12.87 M
-$4.72 M-26.82%
September 30, 2024
Summary
- As of February 7, 2025, XGN quarterly stockholders equity is $12.87 million, with the most recent change of -$4.72 million (-26.82%) on September 30, 2024.
- Over the past year, XGN quarterly shareholders equity has dropped by -$14.64 million (-53.21%).
- XGN quarterly shareholders equity is now -87.32% below its all-time high of $101.47 million, reached on March 31, 2021.
Performance
XGN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
XGN Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -46.5% | -53.2% |
3 y3 years | -45.8% | -85.8% |
5 y5 years | +437.0% | -71.1% |
XGN Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -73.3% | at low | -84.8% | at low |
5 y | 5-year | -73.3% | at low | -87.3% | at low |
alltime | all time | -73.3% | +202.3% | -87.3% | +158.0% |
Exagen Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $12.87 M(-26.8%) |
Jun 2024 | - | $17.59 M(-12.0%) |
Mar 2024 | - | $19.99 M(-11.9%) |
Dec 2023 | $22.69 M(-46.6%) | $22.69 M(-17.5%) |
Sep 2023 | - | $27.50 M(-13.8%) |
Jun 2023 | - | $31.90 M(-11.2%) |
Mar 2023 | - | $35.94 M(-15.4%) |
Dec 2022 | $42.46 M(-50.0%) | $42.46 M(-24.4%) |
Sep 2022 | - | $56.19 M(-12.5%) |
Jun 2022 | - | $64.18 M(-15.7%) |
Mar 2022 | - | $76.16 M(-10.3%) |
Dec 2021 | $84.94 M(+103.0%) | $84.94 M(-6.5%) |
Sep 2021 | - | $90.80 M(-5.8%) |
Jun 2021 | - | $96.38 M(-5.0%) |
Mar 2021 | - | $101.47 M(+142.5%) |
Dec 2020 | $41.84 M | $41.84 M(-5.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | $44.47 M(-7.0%) |
Jun 2020 | - | $47.84 M(-5.3%) |
Mar 2020 | - | $50.54 M(-9.2%) |
Dec 2019 | $55.66 M(-926.5%) | $55.66 M(-5.1%) |
Sep 2019 | - | $58.65 M(-8383.9%) |
Jun 2019 | - | -$708.00 K(-89.5%) |
Dec 2018 | -$6.73 M(+45.2%) | -$6.73 M(-69.6%) |
Dec 2017 | -$4.64 M(-79.1%) | - |
Dec 2015 | -$22.18 M(+57.8%) | -$22.18 M(+19.2%) |
Sep 2015 | - | -$18.61 M(+18.9%) |
Jun 2015 | - | -$15.64 M(-8.4%) |
Mar 2015 | - | -$17.08 M(+21.5%) |
Dec 2014 | -$14.06 M(-3216.6%) | -$14.06 M(+20.6%) |
Sep 2014 | - | -$11.65 M(+65.1%) |
Jun 2014 | - | -$7.05 M(-1664.3%) |
Dec 2013 | $451.00 K(-90.6%) | $451.00 K |
Dec 2012 | $4.82 M | - |
FAQ
- What is Exagen annual stockholders equity?
- What is the all time high annual shareholders equity for Exagen?
- What is Exagen annual shareholders equity year-on-year change?
- What is Exagen quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Exagen?
- What is Exagen quarterly shareholders equity year-on-year change?
What is Exagen annual stockholders equity?
The current annual shareholders equity of XGN is $22.69 M
What is the all time high annual shareholders equity for Exagen?
Exagen all-time high annual stockholders equity is $84.94 M
What is Exagen annual shareholders equity year-on-year change?
Over the past year, XGN annual stockholders equity has changed by -$19.77 M (-46.55%)
What is Exagen quarterly stockholders equity?
The current quarterly shareholders equity of XGN is $12.87 M
What is the all time high quarterly shareholders equity for Exagen?
Exagen all-time high quarterly stockholders equity is $101.47 M
What is Exagen quarterly shareholders equity year-on-year change?
Over the past year, XGN quarterly stockholders equity has changed by -$14.64 M (-53.21%)